Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Shield Thera (STX) Share News

Shield Therapeutics' Feraccru Granted Use Extension In Switzerland

24th Apr 2019 12:22

LONDON (Alliance News) - Shield Therapeutics PLC said on Wednesday said the Swiss Agency for Therapeutic Products has approved the Feraccru product to treat iron deficiency in adults with or is to Read More

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP40,000 In Shares

17th Apr 2019 18:11

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a at Read More

DIRECTOR DEALINGS: Shield Therapeutics Chair Buys GBP40,000 In Shares

17th Apr 2019 18:11

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday Chair James Karis bought 50,000 shares in the company.Karis acquired 46,000 shares at GBP0.815 on Monday, then acquired a at Read More

Shield Therapeutics Cuts Loss In 2018; Licence Payment Lifts Revenue

3rd Apr 2019 09:56

LONDON (Alliance News) - Drug maker Shield Therapeutics PLC said Wednesday its 2018 loss narrowed significantly as revenue surged on a licence payment boost amid a year of "transition" a Read More

Shield Therapeutics Secures Positive Decision On Feraccru's Patent

14th Mar 2019 15:52

LONDON (Alliance News) - Shield Therapeutics PLC on Thursday said its Feraccru patent met the requirements of the European Patent Convention, which will continue to provide protection to Feraccru Read More

Shield Therapeutics Gets Positive Results From Feraccru Study

29th Jan 2019 11:21

LONDON (Alliance News) - Shield Therapeutics PLC on Tuesday reported positive results from a long-term study of its lead treatment for iron deficiency, Ferracru.Shares in the company were a Read More

Shield Therapeutics Expects 2018 Revenue Growth On Licence Payments

24th Jan 2019 14:16

LONDON (Alliance News) - Shield Therapeutics PLC on Thursday said it expects its revenue to surge in 2018 on the back of licence payments for its Feraccru capsules.The pharmaceutical has in Read More

Shield Therapeutics Appoints Director James Karis As Chair

22nd Jan 2019 13:35

LONDON (Alliance News) - Shield Therapeutics PLC said Tuesday that it has promoted board member James Karis to be non-executive chair with immediate effect.Karis has served on Shield's Read More

Shield Therapeutics Partner Norgine Launches Feraccru In UK

5th Dec 2018 11:57

LONDON (Alliance News) - Shield Therapeutics PLC said Wednesday that Norgine BV has launched the company's treatment for iron deficiency, Ferracru, in the UK.In September 2018, Shield, Read More

DIRECTOR DEALINGS: Shield Therapeutics Boss Sterritt Buys More Stock

24th Sep 2018 14:30

LONDON (Alliance News) - Shield Therapeutics PLC on Monday said Chief Executive Carl Sterritt bought more shares in the company in a deal on Friday last week.Sterritt pruchased 88,235 at 34 Read More

Shield Therapeutics Completes Recruitment For Feraccru Trial

13th Sep 2018 11:51

LONDON (Alliance News) - Shield Therapeutics PLC said on Thursday it has completed recruitment of patients for the AEGIS-H2H Phase 3b study of oral Feraccru in subjects suffering from inflammatory Read More

Shield Therapeutics Appoints Hans-Peter Hasler To Board

26th Jul 2018 13:05

LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate is the a Read More

UK Shareholder Meetings Calendar - Next 7 Days

20th Jun 2018 16:09

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25 Read More

Shield Therapeutics Reports Positive Results From Feraccru Study

14th Jun 2018 13:48

LONDON (Alliance News) - Pharmaceutical company Shield Therapeutics PLC said Thursday it has had positive top-line results from its paediatric phase I pharmacokinetics study of its ferric iron is Read More

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

12th Jan 2017 09:04

Shield Therapeutics Reports Widened Pretax Loss In Maiden 2015 Results

14th Jun 2016 09:17

UK Earnings, Trading Statements Calendar - Next 7 Days

7th Jun 2016 15:06

Shield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)

26th Feb 2016 09:17

Shield Therapeutics Raises GBP32.5 Million In Delayed AIM IPO (ALLIPO)

12th Feb 2016 11:50

FTSE 100 Latest

Value8,809.74

Change53.53